JUBILEE HOLDINGS LTD — FULL INVESTOR ANALYSIS

Kenya’s Largest Insurance & Asset Management Group
Share Price (est. NSE Range 2024–2025): ~KSh 180–325
Total 2024 Dividend: KSh 13.50 per share (Interim 2.00 + Final 11.50)
Dividend Yield: Approx. 4 –7% at depending on price.

Jubilee Holdings Ltd (JHL) remains one of East Africa’s most financially solid, diversified, and consistently profitable insurers. Operating across Kenya, Uganda, Tanzania & Burundi, JHL now serves 1.35 million+ lives and manages KSh 200B+ invested across government bonds, T-bills, equities, alternatives, and property.



The company has zero reliance on debt, extremely strong solvency, and a clean years history of never cutting dividends — making it one of the most defensive and resilient counters on the NSE.

1. WHAT JUBILEE DOES (Business Model & Revenue Drivers)

Jubilee operates a three-pillar business model, each contributing differently to revenue, profit stability, and long-term growth:

A. Health Insurance (Largest in East Africa)

Market Position
No.1 in Kenya and Uganda
No.2 in Tanzania

Main Products
Corporate medical schemes, SME health packages, individual & family health covers, NHIF–aligned solutions, micro-health, wellness & telemedicine programs.

Revenue Dynamics
Recurring annual premiums from corporates, government institutions, NGOs, SMEs and individuals. With medical inflation at ~9–12% annually, corporate renewals at higher premiums are a key revenue uplift for JHL.

B. Life Insurance & Pensions

Market Position
#2 in Kenya; expanding in Tanzania & Uganda

Products
Education savings, income protection, endowments, investment-linked plans, group life, annuities, pension solutions.

Revenue Drivers
Long-term premiums and investment returns from policyholder funds — annuities deliver long-term cashflow visibility for 10–20+ years.

C. Asset Management

Assets Under Management
KSh 172B (Institutional) & KSh 8.9B (Retail CIS)

Revenue Drivers
Management & advisory fees, performance earnings and gains on invested funds — supported by high interest government bonds and institutional mandates.

How Jubilee Generates Revenue
Core premium income (Life, Health, General), investment income (bonds, T-bills, equities, property), asset management fees, reinsurance income & profit sharing, and strategic partnership gains (e.g., Allianz).

H1 2025 BUSINESS MODEL

  • Insurance revenue grew +33% (KSh 16.7B vs 12.6B) — strong top-line momentum from corporate renewals, annuities and single-premium life policies.
  • Health dominance continues; premiums rose across regions due to medical inflation.
  • Life & Pensions saw strong inflows driven by single-premium products and annuities.
  • Investment income remains the main profit engine — high bond yields (14–17%) boost returns.

📌 Conclusion: Jubilee’s business model is expanding fast and consistently across all pillars.

2. INCOME STATEMENT ANALYSIS (2024 FULL YEAR)

Insurance Revenue
KSh 25.7B (2024) vs 22.6B (2023) → +14%

Profit Before Tax (PBT)
2024 PBT: KSh 6.22B vs 2.78B → +124% (driven by IFRS 17 valuation shift, large investment returns, improved Life profitability)

Net Profit After Tax
KSh 4.72B vs 2.59B → +82% — evidence of earnings resilience.

EPS
KSh 65 vs 36 → +80% — repositions JHL among top EPS performers on the NSE.

Why Profits Improved

  • Large investment portfolio (188B+)
  • Balanced Life & Health contributions
  • Stable claims ratios
  • Valuation gains on assets
  • Annuitization growth with excellent margins

📌 Conclusion: High profitability from diversified engines — not a single dependency.

⭐ H1 2025 INCOME STATEMENT UPDATE 

  • Insurance Revenue: 16.7B vs 12.6B → +33% (strongest H1 growth in 5+ years).
  • PBT: 3.40B vs 2.95B → +15% (investment gains + premium growth).
  • Net Profit: 3.06B vs 2.51B → +22%.
  • EPS: 41.63 vs 34.59 → +20% (suggests FY 2025 EPS may reach 75–80).

📌 H1 2025 shows strong upward momentum.

3. BALANCE SHEET ANALYSIS (2024)

Total Assets
KSh 213.6B — largest in East African insurance.

Investment Assets
KSh 188.6B — backbone of Jubilee’s profitability (government bonds, T-bills, equities, real estate & alternatives).

Equity / Shareholders’ Funds
KSh 51.18B — extremely strong capitalization.

Liabilities
KSh 153B insurance contract liabilities — normal for a life-heavy insurer.

Financial Strength

  • High solvency ratios
  • Zero meaningful debt
  • Strong liquidity & capital adequacy

📌 Conclusion: One of the strongest insurance balance sheets in Africa.

⭐ H1 2025 BALANCE SHEET UPDATE (DETAILED)

  • Total Assets: KSh 228.4B (+15B in six months).
  • Investment Assets: KSh 206.7B (up from 188.6B) — heavy deployment into long-term bonds.
  • Equity: KSh 53.85B — retained earnings strengthening capital further.

📌 H1 2025 shows accelerated asset accumulation.

4. CASHFLOW ANALYSIS (2024)

Operating + Investing Cashflow
Net inflow: KSh 1.68B

Cash & Cash Equivalents
KSh 5.34B (Dec 2024)

Cashflow drivers: strong premium collections, high investment returns, positive Life & annuity flows.

⭐ H1 2025 CASHFLOW 

Cash & Cash Equivalents: KSh 4.13B (Jun 2025) — decline due to large bond purchases, elevated claims payments and growth in premium receivables. Liquidity remains solid; decline is strategic investment expansion, not distress.

5. DIVIDEND ANALYSIS 

2024 Dividend: KSh 13.50/share (KSh 2.00 interim + KSh 11.50 final)

Dividend Pattern: Never cut dividend; +50% dividend growth in years; one of the highest-paying blue-chips in Kenya.

Dividend Yield: ~4%-6.7% 

⭐ H1 2025 DIVIDEND 

Interim Dividend (2025): KSh 2.00 — reflects confidence in earnings, strong capital position and management commitment to income investors.

6. SHARE PRICE CHARACTERISTICS 

Trading Range: KSh 180–500 over years — low volatility versus peers.

Market Profile: Attracts long-term pension funds; low speculative activity; fairly valued or undervalued based on EPS 65–75 range.

Drivers of Stability

  • Robust fundamentals
  • Large investment income base
  • Strong brand loyalty
  • Low free float (few shares available)

📌 Ideal for income, defensive, and value investors.

7. RISKS 

  • Medical Inflation: High medical costs pressure margins.
  • IFRS 17 Volatility: Profit may fluctuate due to discount rate changes & asset valuations (non-cash but affects reported numbers).
  • Currency Risk: FX exposure across Uganda, Tanzania, Burundi.
  • Investment Risk: Market volatility affects valuation & OCI.

⭐ H1 2025 RISK UPDATE: FX pressure increased slightly; OCI likely negative due to interest rate cycles; claims inflation remains elevated — monitor quarterly.

📌 None of these threaten survival or dividend continuation.

8. INVESTOR RECOMMENDATION (BUY / HOLD / SELL)

  • 🔵 Long-Term Investors → STRONG BUY
  • 🟢 Dividend Investors → STRONG BUY
  • 🟡 Value Investors → BUY
  • 🟠 Growth Investors → BUY
  • 🟤 Short-Term Traders → HOLD
  • 🔴 Speculators / Day Traders → AVOID

9. WHAT EACH INVESTOR TYPE SHOULD WATCH 

  • Long-Term: Solvency ratio trends, investment asset growth, regional premium expansion.
  • Dividend Investors: Free cashflow, medical loss ratio, dividend payout consistency.
  • Value Investors: P/E discount vs regional peers, embedded value (Life business).
  • Short-Term Traders: Quarterly results, interest rate movements.

H1 2025 Notes: Premium receivables increasing — monitor interest rate cycles and quarterly claims inflation.

10. COMPOUNDING GROWTH WITH JUBILEE

Assumptions:

  • KSh 325 share price (current estimated trading range)
  • KSh 13.50 annual dividend
  • 12% long-term compounding rate (EPS growth + dividends reinvested)

10-Year Outcome: → 2.0x – 2.8x total wealth growth

20-Year Outcome: → 4.0x – 6.0x total wealth growth

H1 2025 EPS of 41.63 suggests FY 2025 EPS may reach 75–80, which strengthens long-term compounding and increases fair value upward.

You compound by doing ONLY these two things:

Hold the shares long-term
Compounding needs years.

Reinvest dividends
Don’t withdraw the dividend.
Use it to buy more shares.

Compounding = earn → reinvest → grow → earn more → reinvest → grow more

Even small amounts become big with time.

FINAL VERDICT: STRONG BUY

  • ✔ Strongest balance sheet among Kenyan insurers
  • ✔ Reliable dividend compounder
  • ✔ Rapidly expanding Life & Health segments
  • ✔ Massive investment income engine
  • ✔ Regional diversification
  • ✔ Defensive, stable, and fundamentally sound

Jubilee remains one of the most reliable, high-quality blue-chip stocks on the NSE.

Dividend Summary

Year Interim (KES) Final (KES) Total Dividend (KES)
2025 2.00 11.50 13.50
2024 2.00 12.30 14.30
2023 2.00 11.00 13.00
2022 1.00 13.00 14.00
2021 1.00 8.00 9.00

Post a Comment

0 Comments